某地区小细胞肺癌诊治现况的调查分析

发布时间：2018-12-19 12:56

【摘要】：目的了解目前临床上小细胞肺癌的诊治情况。方法回顾性调查分析某地区6家医院2010.01~2012.04间收治的165例小细胞肺癌患者诊治情况,分别以肿瘤科、呼吸科、非肿瘤科;二级、三级医院进行分组,对分期、生存质量评价、生存时间、接受治疗情况进行统计分析。结果肿瘤科在治疗前进行肿瘤分期、生存质量评价;治疗后评价疾病进展时间(time to progress,TTP)、总生存(overall survival,OS)方面均好于呼吸科及非肿瘤科。三级医院在治疗前进行肿瘤分期、生存质量评价;治疗后评价TTP、OS方面好于二级医院。各级医院,各科室都存在一线治疗不规范用药情况,但差异无统计学意义(均有P0.05)。各医院普遍存在不重视生存评价的问题。结论小细胞肺癌的诊治规范需要进一步重视。
[Abstract]:Objective to investigate the diagnosis and treatment of small cell lung cancer. Methods the diagnosis and treatment of 165 patients with small cell lung cancer (SCLC) in 6 hospitals from 2010.01 to 2012.04 were analyzed retrospectively, including oncology department, respiratory department and non-oncology department. Two-and three-level hospitals were grouped and analyzed statistically on stages, quality of life evaluation, survival time and treatment. Results tumor staging and quality of life (QOL) were evaluated in oncology department before treatment, and the time of disease progression (time to progress,TTP) was evaluated after treatment. The total survival (overall survival,OS) was better than that in respiratory department and non-oncology department. The grade III hospital was better than the second class hospital in the evaluation of tumor stage and quality of life before treatment and the evaluation of TTP,OS after treatment was better than that in the second class hospital. All levels of hospitals and departments have first-line treatment of nonstandard drug use, but the difference is not statistically significant (P0.05). There is a general problem in hospitals that do not attach importance to survival evaluation. Conclusion further attention should be paid to the diagnosis and treatment of small cell lung cancer.
【作者单位】：安徽医科大学教学医院安徽省胸科医院肿瘤科;合肥市第一人民医院肿瘤科;安徽省中医药大学附属医院肿瘤科;皖南医学院附属弋矶山医院肿瘤科;安徽省立第二人民医院肿瘤科;合肥市第三人民医院肿瘤科;
【基金】：安徽省“十二五”临床重点专科建设项目
【分类号】：R734.2;R181

【参考文献】